Market Overview:
The global novel drug delivery systems for cancer therapy market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising incidence of cancer, technological advancements in novel drug delivery systems and increasing demand for minimally invasive therapies. Based on type, the global novel drug delivery systems for cancer therapy market is segmented into embolization particles and liquid embolics. Embolization particles are further sub-segmented into drug eluting beads, polyvinyl alcohol particles, microspheres, gelatin-based embolization devices and holmium-based microspheres. Liquid embolics are further sub-segmented into Onyx and other liquid embolics. Based on application, the global novel drug delivery systems for cancer therapy market is segmented into hospitals, clinics and others segments. Geographically, the global Novel Drug Delivery Systems For Cancer Therapy Market is segmented into North America (U S A Canada), Latin America (Brazil Mexico), Europe (Germany France U K Italy Spain Rest Of Europe), Asia Pacific (Japan China India Australia South Korea Rest Of Asia Pacific) And Middle East & Africa(GCC Countries Saudi Arabia South Africa Rest Of MEA).
Product Definition:
A novel drug delivery system is a method of delivering a drug to a patient that has not been used before. This can include new methods of administering the drug, such as through the use of nanoparticles, or new ways of packaging the drug so that it can more effectively reach the tumor site. The importance of novel drug delivery systems for cancer therapy is that they can improve the effectiveness of treatment by delivering more drugs to the tumor and reducing side effects.
Embolization Particles - Drug Eluting Beads:
Embolization particles - drug eluting beads are used in the treatment of cancer. The embolization process is done to block or plug the blood vessels that supply oxygen and blood cells to tumors. This procedure also reduces the tumor's ability to grow and spread by cutting off its access to oxygen and other vital nutrients.
Polyvinyl Alcohol Particles:
Polyvinyl alcohol (PVA) particles are biodegradable and non-toxic synthetic polymers. PVA is a type of hydrophilic polymer, which means it attracts water to itself.
Application Insights:
The others application segment held the largest share of 70.1% in 2017. The other applications include cancer centers, which are primarily intended for the treatment of advanced stages and metastatic tumors. These centers offer a high level of expertise and technology required to administer novel drug delivery systems for cancer therapy, which drives their demand among other applications.
Hospitals were the most prominent users of these devices as they have access to advanced medical facilities with highly skilled personnel available 24 x 7 x 0 who can administer these devices efficiently and effectively.
Regional Analysis:
North America held the largest share in 2016 owing to the presence of a large number of global players and well-established healthcare infrastructure. Moreover, increasing R&D activities by various organizations to develop novel drug delivery systems for cancer therapy is expected to fuel market growth over the forecast period. Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising disposable income, improving economic conditions, and an increase in consumer awareness regarding early diagnosis of life-threatening diseases such as cancer. In addition, growing medical tourism industry due to low treatment cost coupled with availability of advanced therapies in emerging countries such as India & China will further propel regional market growth during the forecast period.
Moreover, government initiatives encouraging domestic production are expected drive revenue generation from this region over next few years.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the novel drug delivery systems for cancer therapy market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This high incidence rate is expected to drive demand for novel drug delivery systems for cancer therapy over the next few years.
- Rising awareness about advanced therapies: The rising awareness about advanced therapies and their benefits is another key factor driving growth in the novel drug delivery systems for cancer therapy market. Patients are increasingly becoming aware of new technologies such as nanotechnology-based therapies that can offer better treatment outcomes than traditional chemotherapy or radiation therapy methods alone. This growing awareness is expected to boost demand for novel drug delivery systems over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Novel Drug Delivery Systems for Cancer Therapy Market Research Report
By Type
Embolization Particles - Drug Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal Radiation Therapy, Holmium-Based Microspheres, Liquid Embolics - Onyx, Other
By Application
Hospitals, Clinics, Others
By Companies
Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Novel Drug Delivery Systems for Cancer Therapy Market Report Segments:
The global Novel Drug Delivery Systems for Cancer Therapy market is segmented on the basis of:
Types
Embolization Particles - Drug Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal Radiation Therapy, Holmium-Based Microspheres, Liquid Embolics - Onyx, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advanced Medical Isotope Corporation
- Bind Therapeutics
- Boston Scientific Corporation
- BTG plc
- CeloNova BioSciences, Inc.
- Cook Medical, Inc.
- Cospheric LLC
- Covidien, plc
- Eckert & Ziegler BEBIG
- EmboMedics, Inc.
- Kobo Products, Inc.
- Merit Medical Systems, Inc.
- Mo-Sci Corporation
- Nanobiotix
- Polysciences, Inc.
- Sirtex Medical, Inc.
- Terumo Corporation
Highlights of The Novel Drug Delivery Systems for Cancer Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embolization Particles - Drug Eluting Beads
- Polyvinyl Alcohol Particles
- Microspheres
- Gelatin-Based Embolization Devices
- Selective Internal Radiation Therapy
- Holmium-Based Microspheres
- Liquid Embolics - Onyx
- Other
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Novel Drug Delivery Systems for Cancer Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A novel drug delivery system is a technology that allows for the safe and effective delivery of drugs to patients. Novel drug delivery systems can improve the efficacy and safety of cancer therapy by improving the distribution and absorption of drugs into the body.
Some of the major companies in the novel drug delivery systems for cancer therapy market are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc., Terumo Corporation.
The novel drug delivery systems for cancer therapy market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Novel Drug Delivery Systems for Cancer Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Novel Drug Delivery Systems for Cancer Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Novel Drug Delivery Systems for Cancer Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Novel Drug Delivery Systems for Cancer Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Novel Drug Delivery Systems for Cancer Therapy Market Size & Forecast, 2018-2028
4.5.1 Novel Drug Delivery Systems for Cancer Therapy Market Size and Y-o-Y Growth
4.5.2 Novel Drug Delivery Systems for Cancer Therapy Market Absolute $ Opportunity
Chapter 5 Global Novel Drug Delivery Systems for Cancer Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
5.2.1 Embolization Particles - Drug Eluting Beads
5.2.2 Polyvinyl Alcohol Particles
5.2.3 Microspheres
5.2.4 Gelatin-Based Embolization Devices
5.2.5 Selective Internal Radiation Therapy
5.2.6 Holmium-Based Microspheres
5.2.7 Liquid Embolics - Onyx
5.2.8 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Novel Drug Delivery Systems for Cancer Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Novel Drug Delivery Systems for Cancer Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Novel Drug Delivery Systems for Cancer Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
9.6.1 Embolization Particles - Drug Eluting Beads
9.6.2 Polyvinyl Alcohol Particles
9.6.3 Microspheres
9.6.4 Gelatin-Based Embolization Devices
9.6.5 Selective Internal Radiation Therapy
9.6.6 Holmium-Based Microspheres
9.6.7 Liquid Embolics - Onyx
9.6.8 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Novel Drug Delivery Systems for Cancer Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
10.6.1 Embolization Particles - Drug Eluting Beads
10.6.2 Polyvinyl Alcohol Particles
10.6.3 Microspheres
10.6.4 Gelatin-Based Embolization Devices
10.6.5 Selective Internal Radiation Therapy
10.6.6 Holmium-Based Microspheres
10.6.7 Liquid Embolics - Onyx
10.6.8 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
11.6.1 Embolization Particles - Drug Eluting Beads
11.6.2 Polyvinyl Alcohol Particles
11.6.3 Microspheres
11.6.4 Gelatin-Based Embolization Devices
11.6.5 Selective Internal Radiation Therapy
11.6.6 Holmium-Based Microspheres
11.6.7 Liquid Embolics - Onyx
11.6.8 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Novel Drug Delivery Systems for Cancer Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
12.6.1 Embolization Particles - Drug Eluting Beads
12.6.2 Polyvinyl Alcohol Particles
12.6.3 Microspheres
12.6.4 Gelatin-Based Embolization Devices
12.6.5 Selective Internal Radiation Therapy
12.6.6 Holmium-Based Microspheres
12.6.7 Liquid Embolics - Onyx
12.6.8 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Novel Drug Delivery Systems for Cancer Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type
13.6.1 Embolization Particles - Drug Eluting Beads
13.6.2 Polyvinyl Alcohol Particles
13.6.3 Microspheres
13.6.4 Gelatin-Based Embolization Devices
13.6.5 Selective Internal Radiation Therapy
13.6.6 Holmium-Based Microspheres
13.6.7 Liquid Embolics - Onyx
13.6.8 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Novel Drug Delivery Systems for Cancer Therapy Market: Competitive Dashboard
14.2 Global Novel Drug Delivery Systems for Cancer Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
14.3.1 Advanced Medical Isotope Corporation
14.3.2 Bind Therapeutics
14.3.3 Boston Scientific Corporation
14.3.4 BTG plc
14.3.5 CeloNova BioSciences, Inc.
14.3.6 Cook Medical, Inc.
14.3.7 Cospheric LLC
14.3.8 Covidien, plc
14.3.9 Eckert & Ziegler BEBIG
14.3.10 EmboMedics, Inc.
14.3.11 Kobo Products, Inc.
14.3.12 Merit Medical Systems, Inc.
14.3.13 Mo-Sci Corporation
14.3.14 Nanobiotix
14.3.15 Polysciences, Inc.
14.3.16 Sirtex Medical, Inc.
14.3.17 Terumo Corporation
